4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-006723
Chief Medical Officer acquired 264,629 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hewes L. Becker Chief Medical Officer | 2026-01-05 | Grant or award | +264,629 | 264,629 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hewes L. Becker Chief Medical Officer | 2026-01-05 | Grant or award · Stock Option (right to buy) | +528,603 | 528,603 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…